SCHEMBL30607312

CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O

nearest known ligand 0.64

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	8/20	0.60

▸	CALCR	P30988	3/20	0.59

▸	CRHR1	P34998	1/20	0.59

▸	CRHR2	Q13324	1/20	0.59

▸	VIPR2	P41587	3/20	0.59

▸	CCKBR	P32239	1/20	0.58

▸	VIPR1	P32241	2/20	0.58

▸	PTH1R	Q03431	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29410245	0.94	CALCR (0.59)	GLP1RCALCRCRHR1CRHR2VIPR2
SCHEMBL30495587	0.93	GLP1R (0.65)	GLP1RCALCRVIPR2CCKBRVIPR1
SCHEMBL30176491	0.92	VIPR2 (0.60)	GLP1RVIPR2VIPR1
SCHEMBL30432505	0.91	GLP1R (0.66)	GLP1RCALCRCRHR1CRHR2CCKBR
SCHEMBL30970990	0.91	GLP1R (0.71)	GLP1RCALCRVIPR2CCKBRVIPR1
SCHEMBL30432097	0.91	GLP1R (0.59)	GLP1RCALCRCRHR1CRHR2CCKBR
SCHEMBL31182441	0.91	GLP1R (0.66)	GLP1RCALCRCRHR1CRHR2VIPR2
SCHEMBL31182947	0.90	CALCR (0.61)	GLP1RCALCRCRHR1CRHR2CCKBR
SCHEMBL29939727	0.90	GLP1R (0.72)	GLP1RCALCRCCKBRVIPR1
SCHEMBL31603933	0.90	GLP1R (0.69)	GLP1RVIPR2VIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed